306 related articles for article (PubMed ID: 11412299)
1. Mechanisms of interleukin-10-mediated immune suppression.
Akdis CA; Blaser K
Immunology; 2001 Jun; 103(2):131-6. PubMed ID: 11412299
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.
Taylor A; Verhagen J; Blaser K; Akdis M; Akdis CA
Immunology; 2006 Apr; 117(4):433-42. PubMed ID: 16556256
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens.
Akdis CA; Joss A; Akdis M; Blaser K
Int Arch Allergy Immunol; 2001; 124(1-3):180-2. PubMed ID: 11306962
[TBL] [Abstract][Full Text] [Related]
4. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway.
Joss A; Akdis M; Faith A; Blaser K; Akdis CA
Eur J Immunol; 2000 Jun; 30(6):1683-90. PubMed ID: 10898505
[TBL] [Abstract][Full Text] [Related]
5. Human atopen-specific types 1 and 2 T helper cell clones.
Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
[TBL] [Abstract][Full Text] [Related]
6. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
7. [Principles of specific immunotherapy of IgE-induced allergic reactions].
Akdis CA; Blaser K
Ther Umsch; 2001 May; 58(5):274-7. PubMed ID: 11407227
[TBL] [Abstract][Full Text] [Related]
8. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
[TBL] [Abstract][Full Text] [Related]
9. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression.
Melamed D; Friedman A
Eur J Immunol; 1994 Sep; 24(9):1974-81. PubMed ID: 8088317
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
Jutel M; Akdis M; Blaser K; Akdis CA
Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the human IgE response.
de Vries JE; Yssel H
Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
[TBL] [Abstract][Full Text] [Related]
12. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.
Akdis CA; Blaser K
FASEB J; 1999 Apr; 13(6):603-9. PubMed ID: 10094921
[TBL] [Abstract][Full Text] [Related]
13. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.
De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL
Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428
[TBL] [Abstract][Full Text] [Related]
14. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
16. Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4.
Botturi K; Lacoeuille Y; Cavaillès A; Vervloet D; Magnan A
Respir Res; 2011 Feb; 12(1):25. PubMed ID: 21356099
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
Groux H; Bigler M; de Vries JE; Roncarolo MG
J Exp Med; 1996 Jul; 184(1):19-29. PubMed ID: 8691133
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
19. T regulatory cells in allergy and health: a question of allergen specificity and balance.
Taylor A; Verhagen J; Akdis CA; Akdis M
Int Arch Allergy Immunol; 2004 Sep; 135(1):73-82. PubMed ID: 15340251
[TBL] [Abstract][Full Text] [Related]
20. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
